Xiao-Ying Tang

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia

Kyle M. Hebert, M. Pasquini, M. Horowitz, 2020, Biology of Blood and Marrow Transplantation.

Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation.

P. Hari, M. Pasquini, M. Horowitz, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation Using Bone Marrow from a (very) HLA Mismatched Unrelated Donor in the Setting of Post-Transplant Cyclophosphamide Is Feasible and Expands Access to Underserved Minorities

M. Norkin, M. Perales, M. Horowitz, 2020 .

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis

M. Horowitz, B. Shaw, S. Devine, 2020, Biology of Blood and Marrow Transplantation.

Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplant cyclophosphamide: follow-up from a National Marrow Donor Program-sponsored prospective clinical trial.

M. Norkin, M. Perales, J. Pidala, 2022, Transplantation and cellular therapy.

National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

M. Norkin, M. Perales, M. Horowitz, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved Overall Survival of Patients Treated with Abatacept in Combination with a Calcineurin Inhibitor and Methotrexate Following 7/8 HLA-Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of the Center for International Blood and Marrow Transplant Research Database

M. Pasquini, Michael T. Hemmer, L. Kean, 2021, Blood.

Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative

M. Norkin, M. Perales, M. Horowitz, 2020 .

A Real-World Evidence Comparison of 1-Year Overall Survival and Relapse-Free Survival between Patients Treated with Abatacept in Combination with a Calcineurin Inhibitor and Methotrexate Versus Antithymocyte Globulin or Post-Transplant Cyclophosphamide Following Allogeneic Hematopoietic Cell Transpl

M. Pasquini, Michael T. Hemmer, L. Kean, 2022, Blood.